These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22156986)

  • 1. Epstein-Barr virus in multiple sclerosis: a continuing conundrum.
    Lünemann JD
    Neurology; 2012 Jan; 78(1):11-2. PubMed ID: 22156986
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.
    Tzartos JS; Khan G; Vossenkamper A; Cruz-Sadaba M; Lonardi S; Sefia E; Meager A; Elia A; Middeldorp JM; Clemens M; Farrell PJ; Giovannoni G; Meier UC
    Neurology; 2012 Jan; 78(1):15-23. PubMed ID: 22156987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and multiple sclerosis.
    Lovett-Racke AE; Racke MK
    Arch Neurol; 2006 Jun; 63(6):810-1. PubMed ID: 16769860
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus in the development of multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2008 Mar; 8(3):331-3. PubMed ID: 18345964
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus reactivation and multiple sclerosis.
    Torkildsen Ø; Nyland H; Myrmel H; Myhr KM
    Eur J Neurol; 2008 Jan; 15(1):106-8. PubMed ID: 18042233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis?
    Pender MP
    Brain; 2009 Dec; 132(Pt 12):3196-8. PubMed ID: 20008341
    [No Abstract]   [Full Text] [Related]  

  • 7. Exposure to infant siblings during early life and risk of multiple sclerosis.
    Ruprecht K; Perron H
    JAMA; 2005 May; 293(17):2089; author reply 2089-90. PubMed ID: 15870407
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity.
    Lindsey JW; Hatfield LM
    J Neuroimmunol; 2010 Dec; 229(1-2):238-42. PubMed ID: 20826010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins.
    Ristori G; Mechelli R; Anderson J; Mengoni F; Sauzullo I; Annibali V; Cannoni S; Aloisi F; James JA; Salvetti M
    Mult Scler; 2010 Dec; 16(12):1527-8. PubMed ID: 20798134
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus and multiple sclerosis: causation or association?
    Kakalacheva K; Comabella M
    Future Microbiol; 2010 Nov; 5(11):1617-9. PubMed ID: 21133682
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
    Disanto G; Handel AE; Damoiseaux J; Hupperts R; Giovannoni G; Smolders J; Ramagopalan SV
    Mult Scler; 2013 Oct; 19(12):1679-80. PubMed ID: 23828870
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: commentary.
    Hutchinson M
    Mult Scler; 2013 Nov; 19(13):1694-5. PubMed ID: 24218488
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.
    Salzer J; Myhr KM
    Mult Scler; 2013 Nov; 19(13):1692-3. PubMed ID: 24218487
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.
    Peferoen LA; Lamers F; Lodder LN; Gerritsen WH; Huitinga I; Melief J; Giovannoni G; Meier U; Hintzen RQ; Verjans GM; van Nierop GP; Vos W; Peferoen-Baert RM; Middeldorp JM; van der Valk P; Amor S
    Brain; 2010 May; 133(Pt 5):e137. PubMed ID: 19917644
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus, latitude and multiple sclerosis.
    Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of soldiers implicates common virus as MS trigger.
    Kaiser J
    Science; 2022 Jan; 375(6577):133. PubMed ID: 35025651
    [No Abstract]   [Full Text] [Related]  

  • 19. Building a better lymphoma vaccine.
    Ainsworth C
    Nature; 2018 Nov; 563(7731):S52-S54. PubMed ID: 30429570
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune escape by Epstein-Barr virus associated malignancies.
    Münz C; Moormann A
    Semin Cancer Biol; 2008 Dec; 18(6):381-7. PubMed ID: 18996483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.